Share NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026 Feb. 17, 2026 7:30 AM ET Source: NeuroOne Medical Technologies Stock Quote More Company News NeuroOne® Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares NeuroOne® to Host Virtual Investor Webinar on Thursday, March 12, 2026 at 11:30 a.m. Eastern Time NeuroOne® to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time
NeuroOne® Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares
NeuroOne® to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time
